IRIDEX CORP 4
4 · IRIDEX CORP · Filed Mar 9, 2016
Insider Transaction Report
Form 4
IRIDEX CORPIRIX
Steckel Ronald
VP, Operations
Transactions
- Sale
Common Stock
2016-03-08$10.46/sh−2,000$20,925→ 66,875 total - Exercise/Conversion
Stock Option Right to Buy
2016-03-08−3,750→ 6,250 totalExercise: $3.86From: 2013-02-01Exp: 2017-01-01→ Common Stock (3,750 underlying) - Sale
Common Stock
2016-03-08$10.45/sh−6,250$65,301→ 68,875 total - Exercise/Conversion
Common Stock
2016-03-08$3.86/sh−3,750$14,460→ 72,625 total - Sale
Common Stock
2016-03-08$10.45/sh−3,750$39,180→ 68,875 total - Exercise/Conversion
Stock Option Right to Buy
2016-03-08−6,250→ 2,083 totalExercise: $3.99From: 2013-04-16Exp: 2019-04-16→ Common Stock (6,250 underlying) - Exercise/Conversion
Common Stock
2016-03-08$3.99/sh+6,250$24,938→ 75,125 total
Footnotes (4)
- [F1]The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $10.44 to $10.49 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F2]This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.
- [F3]The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.
- [F4]The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.